Login / Signup
David Ray
ORCID
Publication Activity (10 Years)
Years Active: 2019-2021
Publications (10 Years): 3
Top Topics
Clinical Trial
Phase Iii
Neuroendocrine Tumors
Health Insurance
Top Venues
Patient related outcome measures
Future oncology (London, England)
Journal of medical economics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Bernard Tawfik
,
David Ray
,
Meghan Moynihan
,
Princic Nicole
Costs of treatment change following first-line somatostatin analog monotherapy among patients with neuroendocrine tumors.
Journal of medical economics
24 (1) (2021)
Nicole M Zimmerman
,
David Ray
,
Princic Nicole
,
Meghan Moynihan
,
Callisia N Clarke
,
Alexandria T Phan
Exploration of machine learning techniques to examine the journey to neuroendocrine tumor diagnosis with real-world data.
Future oncology (London, England)
17 (24) (2021)
Koenraad H Blot
,
Luc Duchateau
,
Benedicte Lescrauwaet
,
Nilani Liyanage
,
David Ray
,
Beloo Mirakhur
,
Aaron I Vinik
A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial.
Patient related outcome measures
10 (2019)